METHODS: Using data From the Michigan Bariatric Surgery Collaborative (MBSC), we identified patients undergoing primary, non-revisional bariatric surgery who had baseline and 1 year follow-up data (n=14,063). We ascertained opioid use using a patient-reported survey methodology previously validated within MBSC. Patients were asked whether they used "Prescription pain killers" with a list of commonly prescribed opioid medications.
RESULTS: In this cohort, 76% (n=10,697) of patients denied opioid use preoperatively (Table  1) . Nearly 10% of these opioid naïve patients reported new persistent opioid use one year after surgery. This represents a 60% increase compared to general surgical patients (9.7% vs 6.0%). Among patients who reported preoperative opioid use (n=3,366), 39.7% no longer reported opioid use at one year after surgery. Overall, 27% of post-bariatric surgery patients report opioid use one year following bariatric surgery. CONCLUSIONS: Opioid naïve patients undergoing bariatric surgery develop much higher rates of new persistent opioid use compared to other general surgical patients. Furthermore, those with baseline opioid use have a small rate of remission. Given the elevated risk of cross-addiction in these patients, providers should pay special attention to opioid use during the post-surgical period.
